Description

Baorto et al evaluated pediatric patients with febrile neutropenia following cancer therapy. They used the absolute monocyte count to stratify patients as to risk of serious complications. The authors are from Washington University, University of Texas Southwestern Medical Center and M.D. Anderson Cancer Center.


 

Outcomes: bacteremia. Severe cases involved admission to the ICU and/or death.

 

Patient selection: pediatric patient > 12 months old with febrile neutropenia (absolute neutrophil count < 500 per µL at presentation) following chemotherapy. Temperature was >= 38°C taken orally or at the axilla.

 

All patients were treated with parenteral antibiotics at presentation.

 

absolute monocyte count per µL =

= (percent monocytes) * (WBC count per µL) / 100

 

absolute phagocyte count per µL =

= ((percent neutrophils) + (percent monocytes)) * (WBC counter per µL) / 100

Absolute Monocyte Count

Risk Group

>= 250 per µL

very low risk

155 to 249 per µL

low risk

30 to 155

increased risk

< 30 per µL

highest risk

 

Patients with an absolute monocyte count >= 150 per µL are potential candidates for outpatient management.

 


To read more or access our algorithms and calculators, please log in or register.